These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 12661407)
1. [Molecular biology of polyglutamine diseases]. Owecki M; Kozubski W Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407 [TBL] [Abstract][Full Text] [Related]
2. CAG repeat disorder models and human neuropathology: similarities and differences. Yamada M; Sato T; Tsuji S; Takahashi H Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457 [TBL] [Abstract][Full Text] [Related]
3. [Dynamic mutations in hereditary neurodegenerative disorders]. Nilssen O Tidsskr Nor Laegeforen; 1999 Aug; 119(20):3021-7. PubMed ID: 10504853 [TBL] [Abstract][Full Text] [Related]
4. [Growing genes cause neurological diseases]. Johansson J; Holmgren G; Forsgren L; Holmberg M Lakartidningen; 1999 Feb; 96(8):897-900. PubMed ID: 10089735 [TBL] [Abstract][Full Text] [Related]
5. [Polyglutamine diseases: a pathologic view]. Yamada M Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499 [TBL] [Abstract][Full Text] [Related]
6. [The advances in research on phosphorylation of polyglutamine disease]. Zhou YF; Jiang H; Tang JG; Tang BS Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic strategies for the polyglutamine diseases]. Nagai Y; Popiel HA; Fujikake N; Toda T Brain Nerve; 2007 Apr; 59(4):393-404. PubMed ID: 17447526 [TBL] [Abstract][Full Text] [Related]
8. Trinucleotide repeat expansion in neurological disease. La Spada AR; Paulson HL; Fischbeck KH Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766 [TBL] [Abstract][Full Text] [Related]
9. Dynamic mutation and human disorders: the spinocerebellar ataxias (review). Costa Lima MA; Pimentel MM Int J Mol Med; 2004 Feb; 13(2):299-302. PubMed ID: 14719138 [TBL] [Abstract][Full Text] [Related]
11. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. Bauer PO; Nukina N J Neurochem; 2009 Sep; 110(6):1737-65. PubMed ID: 19650870 [TBL] [Abstract][Full Text] [Related]
12. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976 [TBL] [Abstract][Full Text] [Related]
13. [Neurodegenerative polyglutamine expansion diseases: physiopathology and therapeutic strategies]. Ravache M; Abou-Sleymane G; Trottier Y Pathol Biol (Paris); 2010 Oct; 58(5):357-66. PubMed ID: 20299163 [TBL] [Abstract][Full Text] [Related]
14. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein]. Nakamura K Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815 [TBL] [Abstract][Full Text] [Related]
15. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Wanker EE Biol Chem; 2000; 381(9-10):937-42. PubMed ID: 11076024 [TBL] [Abstract][Full Text] [Related]
16. TATA-binding protein in neurodegenerative disease. van Roon-Mom WM; Reid SJ; Faull RL; Snell RG Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetics and biomarkers of polyglutamine diseases. Katsuno M; Banno H; Suzuki K; Takeuchi Y; Kawashima M; Tanaka F; Adachi H; Sobue G Curr Mol Med; 2008 May; 8(3):221-34. PubMed ID: 18473821 [TBL] [Abstract][Full Text] [Related]
20. [The Role of Mutant RNA in the Pathogenesis of Huntington's Disease and Other Polyglutamine Diseases]. Bogomazova AN; Eremeev AV; Pozmogova GE; Lagarkova MA Mol Biol (Mosk); 2019; 53(6):954-967. PubMed ID: 31876275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]